Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Glycine,Calcium
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Approved
Sponsor : Cipla
Deal Size : $48.6 million
Deal Type : Acquisition
Cipla to Acquire South Africa-based Actor Pharma
Details : Through the acquisition, Cipla strengthen its wellness portfolio by gaining access of Nozohaem (glycine and Calcium), a unique, gel treatment for nosebleeds that stops the bleeding in moments.
Brand Name : Nozohaem
Molecule Type : Small molecule
Upfront Cash : $48.6 million
September 05, 2023
Lead Product(s) : Glycine,Calcium
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Approved
Sponsor : Cipla
Deal Size : $48.6 million
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?
Reset All
